BTL-785F Device for Non-invasive Lipolysis and Circumference Reduction of the Abdomen

Inclusion Criteria: * Healthy male or female subjects over 21 years of age seeking treatment for abdominal circumference reduction * Subjects should be able understand the investigative nature of the treatment, the possible benefits and side effects, and must sign the Informed Consent Form * Presence of clearly visible fat deposits in the abdominal area as deemed appropriate by the Investigator (e.g. by pinch test or ultrasound fat thickness measurement) * Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation. * No procedure for abdominal fat reduction (including cellulite treatment) in the last six months. * Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting a significant change of weight in either direction during study participation. * Willingness to comply with study instructions and to return to the clinic for required visits. Exclusion Criteria: * Bacterial or viral infection, acute inflammations * Impaired immune system * Isotretinoin use in the past 12 months * Skin related autoimmune diseases * Radiation therapy and/or chemotherapy * Poor healing and unhealed wounds in the treatment area * Metal implants * Permanent implant in the treated area * Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body * Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles * History of any type of cancer * Active collagen diseases * Cardiovascular diseases (such as vascular diseases, peripheral arterial disease, thrombophlebitis and thrombosis) * Pregnancy/nursing or IVF procedure * History of bleeding coagulopathies, use of anticoagulants * Any active condition in the treatment area, such as sores, psoriasis, eczema, etc. * Any surgical procedure in the treatment area within the last three months or before complete healing * Poorly controlled endocrine disorders, such as diabetes * Acute neuralgia and neuropathy * Kidney or liver failure * Sensitivity disorders in the treatment area * Varicose veins, pronounced edemas * Previous liposuction in the treatment area in the last six months * Unstable weight within the last 6 months (change in weight ± 3%) * Previous body contouring or cellulite treatments in the abdominal area in the last six months * Any other disease or condition (e.g. hernia) at the investigator discretion that may pose risk to the patient or compromise the study